This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 278453.
ClinicalTrials.gov Identifier:
NCT02035540
News
“For me, it’s a day at work, for the child it’s the rest of their life”
Great Ormond Street Hospital (GOSH) is situated in the heart of London and is the world's oldest children hospital (est. 1852) with the patronage of Queen Elisabeth herself. Today the hospital is considered an international... [more]
Final project report - Summary
Beginning in January 2012, the European Union has funded the European Clinical Study for the Application of Regenerative Heart Valves, coordinated by Hannover Medical School, Germany, with a grant of 5.2 Million Euros over a... [more]
ESPOIR project closing meeting held in Zurich in December 2016
Long-term follow up initiated - the European post-authorisation study on regenerative pulmonary heart valve replacement enrolled 120 patients [more]
Welcome to ESPOIR
Beginning in January 2012, the European Union will fund the European Clinical Study for the Application of Regenerative Heart Valves (ESPOIR) trial, coordinated by the Hannover Medical School, Germany, with a grant of 5.2 Million Euros for a period of four years. The aim of ESPOIR is to transplant a heart valve, which is tolerated by the patient’s immune system, lasts a lifetime and, for children, even holds the potential to grow with the patient.